Paternal Nicotine Exposure Linked to Altered Glucose Metabolism in Offspring, Mouse Study Shows
Mouse study finds paternal nicotine exposure alters offspring glucose metabolism and may raise diabetes risk, prompting calls for better male preconception care.
A new laboratory study published in the Journal of the Endocrine Society reports that paternal nicotine exposure can change how offspring process sugar, potentially increasing their risk of metabolic disease. The research, led by investigators at the University of California, Santa Cruz, used a mouse model in which adult males consumed nicotine in drinking water before fathering litters. The term paternal nicotine exposure appears throughout the findings as the researchers traced metabolic differences in the next generation.
Study Design and Research Team
The investigation followed offspring of male mice given pure nicotine in their drinking water and compared them with pups sired by unexposed males. The design intentionally isolated nicotine from the many other chemicals present in cigarette smoke and e-cigarette liquids so the team could identify nicotine-specific effects. Senior author Raquel Chamorro-Garcia and colleagues at UC Santa Cruz reported the protocol and outcomes in the peer-reviewed journal.
Key Metabolic Findings in Offspring
Researchers observed measurable changes in glucose regulation among the offspring of nicotine-exposed fathers. Female offspring showed lower circulating insulin and lower fasting glucose compared with controls, while male offspring also displayed reduced blood glucose and alterations in liver function. The pattern of changes suggests that paternal nicotine exposure modifies pathways involved in sugar handling and energy balance across sexes.
Potential Links to Diabetes and Liver Disease
The study team warned that shifts in insulin and glucose homeostasis could translate into a higher long-term risk of metabolic conditions, including diabetes. The authors noted that metabolic dysfunction is also a contributor to liver disorders such as metabolic dysfunction-associated steatotic liver disease. While the mouse data do not prove disease development in humans, the physiological changes observed are consistent with pathways that raise diabetes susceptibility.
Implications for Male Preconception Health
Investigators emphasized the importance of addressing male health before conception as part of broader preconception care. Chamorro-Garcia highlighted that exposures in fathers—here exemplified by nicotine—may have consequences for their children’s metabolic health, underscoring that paternal behaviors are relevant to intergenerational disease risk. The findings add to a growing literature urging attention to men’s health in family planning and public health messaging.
Public Health Context and Tobacco Use
The study occurs against a backdrop of a substantial diabetes burden in the United States, where tens of millions of people live with the condition and face higher risks of cardiovascular and kidney complications. Public health officials continue to view tobacco use, including nicotine delivered by cigarettes and electronic devices, as a major preventable driver of poor health. The researchers argue that reducing nicotine exposure in prospective fathers could be a modifiable factor to help curb the rise of metabolic disease.
Funding, Authors, and Limitations
The paper lists coauthors Stephanie Aguiar, Truman Natividad, Daniel Davis, and Carlos Diaz-Castillo and acknowledges funding from the U.S. National Institutes of Health and University of California sources. The team noted key limitations, including the fact that the work was conducted in mice and may not fully replicate human biology. They also stressed that the experiment used pharmaceutical-grade nicotine alone, so interactions with other tobacco constituents were not assessed.
The research suggests a previously underappreciated avenue by which paternal exposures before conception may program offspring metabolism. Further studies will be needed in larger animal cohorts and, where possible, in human populations to determine the magnitude of the risk and the mechanisms involved. Until then, clinicians and public health professionals may consider these findings when advising prospective parents about tobacco and nicotine cessation.
